ArticleACS pharmacology & translational science2021

Selective Endocannabinoid Reuptake Inhibitor WOBE437 Reduces Disease Progression in a Mouse Model of Multiple Sclerosis.

Ines Reynoso-Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.